RESEARCHER PROFILE (Filmed January 2024)
Laureate Professor Clare Collins AO
Nutrition and Dietetics in the School of Health Sciences,
University of Newcastle & Director, Food and Nutrition Research Program
Hunter Medical Research Institute
New South Wales, Australia
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
Prof Collins is Laureate Professor in Nutrition and Dietetics in the School of Health Sciences, College of Health, Medicine and Wellbeing. She has received three prestigious NHMRC Research Fellowships, is currently Director of Hunter Medical Research Institute, Food and Nutrition Program and been a dietitian for over 40 years.
Laureate Professor Collins has made major contributions to our knowledge on the impact of improving diet quality and food patterns on health and wellbeing outcomes. Her research in precision and personalised nutrition is driving a paradigm shift in technologies that improve delivery of medical nutrition therapy to under-served groups based on life-stage, socio-economic status or geographic location, for whom the chronic disease burden is 40-50% higher. This is generating new knowledge on cost-effective models of care that are available online or can be embedded in health settings.
Her passion was fuelled growing up as one of nine children and being in the first generation of her family to have the opportunity complete year 12 and go to university. She learnt from an early age the meaning of hard work, the importance of grasping opportunities when they arose and the importance of share the fruits of those opportunities.
Laureate Professor Collins is a Fellow of four prestigious bodies, the Australian Academy of Health and Medical Sciences, the Nutrition Society of Australia, Dietitians Australia, and the Royal Society of NSW. As the most successful research dietitian globally, her team includes dietitians, nutritionists, biochemists, computer scientists, biomedical engineers and software developers.
She has been awarded over $29 million dollars in research grants, published over 450 manuscripts and supervised 35 PhD and Master candidates to completion so far. Laureate Professor Collins is a great believer in sharing her knowledge through translation of nutrition science to benefit the public.
-
Investigating the benefits of donor human milk for preterm infants
Together, SAHMRI and Lifeblood are leading a consortium to revolutionise the way human milk, and novel products made from human milk, are used as nutritional and medical interventions to improve health outcomes in vulnerable infants, but with potential application for a diverse range of medical indications.
Currently, babies who are born early preterm – before 32 weeks – are given donor milk when their own mother’s milk is not available or in short supply. Whether donor milk is beneficial for babies born just a few weeks early is unclear, as very little research has been undertaken with these babies.
The GIFT Trial will soon commence as an investigation between SAHMRI, the University of Adelaide, the Red Cross Lifeblood Milk Bank conducted at five sites across three states in Australia.
-
Patient reported outcomes in the diagnosis and treatment of lymphoma
Dr. Elizabeth Goodall (BMedSci Hons, MBBS Hons, FRACP, FRCPA) is a PhD student and early career researcher with La Trobe University and the Olivia Newton John Cancer Research Institute (ONJCRI), and Haematologist at Austin Health and Monash Health, Melbourne.
Her specific interest in how patients experience their illness and treatment forms the basis for her research in improving patient outcomes. This research comes at a pivotal time in modern lymphoma management with an ever-increasing number of treatment options available and renewed focus on each patient’s journey.
-
Causal genes and pathogenic mechanisms underlying gastrointestinal diseases
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
